(Q39959509)

15 September 2017

title

Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer (English)

1 reference

15 September 2017

1 reference

1 reference

Weiming Zhao

1

1 reference

15 September 2017

Yong Xu

2

1 reference

15 September 2017

Deling Kong

3

1 reference

15 September 2017

Ranlu Liu

4

1 reference

15 September 2017

Zijian Zhang

5

1 reference

15 September 2017

Chengjun Jin

6

1 reference

15 September 2017

Zhihong Zhang

7

1 reference

15 September 2017

Youcheng Xiu

8

1 reference

15 September 2017

publication date

17 July 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

27

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

539-547

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

15 September 2017

1 reference

Hormone refractory prostate cancer: Management and advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

RNA interference technologies and their use in cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Gene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

RNAi therapeutics: how likely, how soon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Unlocking the potential of the human genome with RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific prostate-specific antigen promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Mechanisms of androgen-refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

STATs and gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

Gene therapy death prompts review of adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.05.003

10.1016/J.UROLONC.2008.05.003

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference